Indication
Preexposure Prophylaxis for HIV
2 clinical trials
4 products
Clinical trial
A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Preexposure Prophylaxis in Cisgender Men and Transgender Women Who Have Sex With Men, and Are at High Risk for HIV-1 InfectionStatus: Completed, Estimated PCD: 2023-08-04
Product
ISLProduct
FTC/TAFProduct
FTC/TDFClinical trial
Sustainable Healthcenter Implementation PrEP Pilot StudyStatus: Completed, Estimated PCD: 2018-11-01
Product
TDF + FTC